Kangstem Biotech Co., Ltd. (KOSDAQ:217730)

Kangstem Biotech Revenue

Kangstem Biotech had revenue of 641.99M KRW in the quarter ending June 30, 2026, a decrease of -81.13%. This brings the company's total for the last twelve months to 3.03B, down -76.24% year-over-year. In the year 2025, Kangstem Biotech had annual revenue of 3.57B, down -53.88%. That makes Kangstem Biotech the 42,091st largest company in the world by revenue and 2,558th in South Korea.

• Revenue (ttm): 3.03B
• Revenue Growth: -76.24%
• P/S Ratio: 58.61
• Revenue / Employee: 30.35M
• Employees: 100
• Market Cap: 177.86B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Stem Cell 2.37B 66.3%
• Cosmetics 1.20B 33.7%

Fiscal year ended Dec 31, 2025 See the full Kangstem Biotech breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.57B	-4.17B	-53.88%
Dec 31, 2024	7.75B	-4.96B	-39.03%
Dec 31, 2023	12.70B	-3.60B	-22.06%
Dec 31, 2022	16.30B	3.90B	31.41%
Dec 31, 2021	12.40B	3.27B	35.75%

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error